English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA Regenstrief Institute-led review of studies on proactive health services for chlamydia and gonorrhea has found that rates of presumptive treatment — antibiotics prior to laboratory test confirmation — varies widely.
Tag: Chlamydia
Doxycycline does not prevent STIs among cisgender women
Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women.
Story Tips from Johns Hopkins Experts on Covid-19
Vaccines that prevent infection by SARS-CoV-2, the virus that causes COVID-19, are being rolled out around the world. Below are five things about vaccine science of which you may be unaware. Additionally, here is a video about how vaccines are determined safe.
NATIONAL INSTITUTES OF HEALTH ESTABLISHES CENTER AT LAWRENCE LIVERMORE TO DEVELOP CHLAMYDIA VACCINE
A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory (LLNL). The center includes two University of California campuses – Irvine and Davis.
New STD Data Represent Urgent Call for Action
The continued steep increase in incidence of sexually transmitted diseases reported in the 2018 data released by the U.S. Centers for Disease Control and Prevention Tuesday, is a cause for deep concern about dangerous gaps in our public health infrastructure.